A protective role for endothelial nitric oxide synthase in glocals such as peroxynitrite that initiate lipid peroxidation merulonephritis. In acute glomerulonephritis (GN), increased and can damage proteins [2] . However, results from studnitric oxide (NO) production occurs, suggesting a pathophysioies attempting to inhibit excessive NO production in logical role for NO in the disease process. Although NO potenacute models of GN using competitive NO inhibitors are tially could have both toxic as well as protective effects, its exact inconclusive and sometimes conflicting [1] . In many of role in the pathophysiology of GN is unclear and may depend on the NOS isoform generating NO. The protective effects of these studies exacerbation of the disease occurred sug-NO such as prevention of leukocyte and platelet activation and gesting that part of the NO response is protective. In adhesion have been attributed to NO generated by endothelial general, these beneficial effects of NO have been attribnitric oxide synthase (eNOS). Evidence for a beneficial role uted to the low levels of NO being generated by the for eNOS includes the demonstration of reduced eNOS expresconstitutive isoform of nitric oxide synthase (NOS) exsion in experimental models of GN as well as human biopsy specimens that is mostly likely due to endothelial cell necrosis.
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pressed by the endothelium (eNOS).
Reduced NO production in GN also may occur through reacNitric oxide radicals generated by eNOS play an imtion of NO with superoxide anions or the myeloperoxidase portant role in the regulation of vascular homeostasis by (MPO)/hypochlorous acid (HOCL) system. Further evidence inducing vasorelaxation and inhibiting platelet adhesion has been provided by the observation that in several experiand aggregation to the endothelium [3] [4] [5] . In addition, mental models of GN, glomerular injury is exacerbated following treatment with non-selective NO inhibitors. Finally, the several studies have demonstrated that eNOS derived development of GN is severely aggravated in mice lacking NO is a critical modulator of leukocyte-endothelial cell a functional gene for eNOS as compared to wild-type mice, interactions. Inhibition of NO production has been shown providing direct support for a protective role of eNOS-derived to promote leukocyte rolling and firm adherence in the NO in acute GN. microcirculation and in several models of inflammation NO donating agents or supplementation with l-arginine has been found to reduce the extent of neutrophil-mediIt is well established now that acute glomerulonephriated tissue injury [1, 6] . Here, we will discuss the evidence tis is associated with increased glomerular synthesis of that eNOS-derived NO radicals exhibit properties that nitric oxide (NO) [1] . In particular, this has been demonare beneficial in limiting inflammatory reactions in acute strated in several well-defined animal models of glomeruglomerulonephritis. lonephritis such as nephrotoxic nephritis, active Heymann nephritis and anti-Thy-1 nephritis. In these models, high amounts of NO are generated by the inducible form of EXPRESSION OF eNOS NOS expressed in infiltrating inflammatory cells such IN GLOMERULONEPHRITIS as neutrophils and monocytes. These observations have
In the kidney, eNOS is constitutively expressed by added NO to the list of mediators contributing to the normal glomerular endothelium and interstitial vessels development of tissue injury. Indeed, excessive amounts [7] . Over the past few years, several studies have been of NO can be directly cytostatic or cytotoxic by its reacreported regarding the expression of eNOS in GN emtion with iron sulfur groups and DNA. NO also may react ploying experimental animal models of GN as well as with superoxide anions generating highly reactive radirenal biopsies from patients with various forms of GN [8] [9] [10] [11] [12] [13] . The first report studying the status of eNOS in experimental GN demonstrated a slight, biphasic, in-crease in glomerular eNOS mRNA during the course of anti-Thy-1 nephritis [8] . In rat as well as murine nephro- 2002 by the International Society of Nephrology toxic nephritis models, a significant focal loss of glomeru-GN in the PVG/c rat, we have recently observed that treatment with L-NAME exacerbated proteinuria and lar eNOS expression has been shown using immunogold electron microscopy and immunohistochemistry, resincreased systolic blood pressure [18] . Compared to nontreated rats, a marked increase in platelet aggregation pectively [12, 14] . Interestingly, the diminished eNOS expression in the rat model was reversed by treatment was found whereas no differences in leukocyte accumulation were observed. with a non-selective NO inhibitor [l-arginine methylester (L-NAME)]. Using immunohistochemistry, the loss of In contrast to these detrimental consequences, beneficial effects of NO inhibition in experimental GN have eNOS expression also has been observed in an experimental model of anti-myeloperoxidase (MPO) associalso been reported. In the rat anti-Thy-1 model of GN, Narita and colleagues have shown that infusion of a ated GN induced by immunizing Brown Norway rats with MPO followed by an unilateral perfusion of the left single dose of the l-arginine analog, L-NMMA, reduces proteinuria and inhibits mesangiolysis to a large extent kidney with a neutrophil lysosomal extract containing proteolytic enzymes, MPO and H 2 O 2 [11] . In this model, [19] . In these studies, similar results were obtained using a low protein diet or a diet depleted of l-arginine. Furimmunohistochemical detection of platelets demonstrated that, at sites where eNOS immunoreactivity was thermore, in spontaneous murine models of chronic autoimmune GN such as the MRL/lpr/lpr and New Zealand absent, massive adhesion and aggregation of platelets occurred, emphasizing the importance of eNOS-derived Black/White (NZB/W) mice, treatment with L-NMMA has been shown to ameliorate proteinuria and the devel-NO in inhibiting platelet adhesion and aggregation. Although other factors may be involved, the decrease of opment of proliferative GN [20, 21] . In contrast, however, no significant effect on GN was found when iNOS glomerular eNOS expression in this model is probably due to endothelial cell necrosis, since at these sites immudeficient mice were backcrossed to MRL/lpr/lpr mice, although renal vasculitis and arthritis were reduced [22] . nohistochemical staining for a rat endothelial cell marker (RECA-1) was also absent.
Based on the studies using pharmacological inhibition of NO production described above, the exact role of NO Studies employing immunohistochemistry to investigate eNOS expression in human renal biopsy specimens in the pathogenesis in GN remains unclear. In particular, the use of l-arginine analogs that lack NOS isoform have demonstrated a loss of glomerular eNOS expression in IgA nephropathy, lupus nephritis and Wegener's specificity complicates interpretation of the results. Nevertheless, these studies have provided indirect evidence granulomatosis that was most prominent in areas of severe glomerular injury [10, 13] . Moreover, an inverse that at least part of the NO response in GN, most likely generated by eNOS, is protective. correlation between the extent of eNOS expression and the degree of glomerular injury was found in IgA nephropathy and lupus nephritis [10] .
EFFECTS OF eNOS DEFICIENCY Taken together, the above-mentioned studies indicate ON GLOMERULONEPHRITIS that the development of glomerulonephritis is associated Because most conventional NO inhibitors do not diswith a reduction in overall eNOS expression that could tinguish between the NOS isoforms, separate lines of potentially exacerbate the inflammatory response.
mice have been generated with targeted disruption of the genes for inducible NOS (iNOS), neuronal NOS EFFECTS OF PHARMACOLOGICAL (nNOS) as well as eNOS [23] . These gene-targeted mice
INHIBITION OF eNOS ACTIVITY
have allowed the direct evaluation of NO generated by ON GLOMERULONEPHRITIS one of the NOS isoforms in various physiological and pathophysiological circumstances. Until recently, studies examining the effects of NO in GN relied on the use of structural variants of l-arginine
Mice lacking a functional gene for eNOS (eNOS Ϫ/Ϫ mice) were originally generated to study the role of that compete with l-arginine for binding to the active site of NOS. So far, results from these studies have been eNOS derived NO in blood pressure regulation [24, 25] . These studies showed that eNOS Ϫ/Ϫ mice are indistininconclusive and in some cases conflicting data exist. In many of these studies, the use of l-arginine analogs such guishable from wild-type (WT) mice in general appearance and histology, but have significantly increased blood as L-NAME has been found to worsen disease. For example, in rat nephrotoxic nephritis as well as in modpressures and an impaired vasorelaxation response to acetylcholine. In addition, baseline and thrombin-induced els of autoimmune Heymann nephritis treatment with L-NAME exacerbated proteinuria [15] [16] [17] . Furtherleukocyte rolling and adherence are significantly elevated in the mesentery of eNOS Ϫ/Ϫ mice compared to more, depletion of arginine levels through infusion of arginase resulted in more glomerular thrombosis and WT mice that is associated with an increased surface expression of P-selectin [26] . aggravated glomerular disease in rat nephrotoxic nephritis [15] . In the Thy-1 model of mesangioproliferative
To specifically determine the role of eNOS derived NO in GN, we studied the course of murine accelerated However, other potential pathophysiological mechanisms may be operative in GN that could affect eNOS anti-glomerular basement membrane (anti-GBM) in eNOS Ϫ/Ϫ mice and C57BL/6j WT mice [12] . In this expression and activity. In vitro studies have demonstrated that proinflammamodel, GN was induced by preimmunization with sheep immunoglobulin G followed by intravenous administratory cytokines such as TNF-␣ lower eNOS expression in cultured endothelial cells [27] . Furthermore, eNOStion of a subnephritogenic dose of sheep anti-mouse GBM antibody seven days later. In WT mice, GN develderived NO may react with other free radicals such as superoxide leading to oxidative inactivation of NO [27] . oped characterized by early (24 hours) glomerular neutrophil accumulation and glomerular thrombosis that Both TNF-␣ and superoxide production have been documented in GN and could potentially alter bioactivity of persisted until day 10. In addition, at day 10 glomerular hypercellularity and crescent formation in 17% of glo-NO [13, 28, 29].
More recently, an important role for myeloperoxidase meruli were observed. In eNOS Ϫ/Ϫ mice, GN was severely aggravated. In comparison to WT mice, increased (MPO) in modulating NO availability has been postulated. The heme protein MPO is the most abundant morbidity was observed and serum blood urea nitrogen (BUN) levels were elevated indicating severe renal imenzyme in neutrophils where it is contained in the azurophilic granules [30] . However, upon neutrophil activapairment in these mice. The most prominent feature of the disease in eNOS Ϫ/Ϫ mice was extensive glomerular tion MPO can be readily released into phagocytic vacuoles as well as the extracellular space. MPO catalyzes capillary thrombosis often occluding all capillaries. At day 10, a modest increase in glomerular neutrophil influx the oxidation of chloride by hydrogen peroxide resulting in the formation of hypochlorous acid (HOCL) that can was observed. Overall antibody depositions, glomerular endocapillary hypercellularity and crescent formation, react with a variety of cellular substrates including thiols, nucleotides and amines [30] . As such, MPO catalyzed however, were similar to that in WT mice.
To extend these observations, we recently studied the HOCL formation contributes to the microbial killing function of neutrophils. However, when generated extraeffect of eNOS deficiency on heterologous nephrotoxic nephritis induced by a single dose of rabbit anti-mouse cellularly it also may induce tissue injury. The interaction between MPO and NO has recently GBM antibodies (E. Steenbergen, unpublished results). Compared to WT mice, the glomerular neutrophil influx been investigated [31] . This study demonstrated that NO can serve as a substrate for MPO in the presence of was markedly enhanced in eNOS Ϫ/Ϫ mice at two hours [5.4 Ϯ 2.6 (N ϭ 7) vs. 2.4 Ϯ 1.6 (N ϭ 8), P Ͻ 0.02 in H 2 O 2 , raising the possibility that MPO functions as a catalytic sink for NO in vivo. Furthermore, Zhang and eNOS Ϫ/Ϫ and WT mice, respectively]. Also, at 3 days after induction of the disease, elevated serum BUN levels colleagues have demonstrated that HOCL can react with l-arginine to form novel chlorinated metabolites [31, 32]. were detected whereas an increase in overall glomerular capillary thrombosis was observed. Taken together, these Interestingly, these chlorinated l-arginine compounds exhibited inhibitory effects on endothelium-dependent results provide further evidence for a protective role for eNOS-derived NO production in glomerulonephritis.
vasorelaxation in vivo as well as in vitro, displaying similar pharmacological properties as conventional NOS inhibitors such as L-NAME. From these results the authors FACTORS THAT MAY AFFECT eNOS postulated that chlorinated l-arginine metabolites repre-EXPRESSION AND ACTIVITY sent endogenous competitive inhibitors of eNOS. These IN GLOMERULONEPHRITIS studies indicate that activation of the MPO/HOCL sysAlthough eNOS expression is constitutive, in vitro tem may limit the bioavailability of NO in vivo, an effect studies have demonstrated that its expression can be that would be especially relevant at sites of inflammation subject to modulation. Several factors have been identiwhere MPO, NO and H 2 O 2 are present. Whether these fied that either increase (such as, shear stress) or decrease MPO related mechanisms play a role in GN remains to [for example, hypoxia, endotoxin and tumor necrosis be determined. In this respect, it is interesting to note factor-␣ (TNF-␣)] eNOS expression [27] . Thus, pathothat catalytically active MPO has been detected in GN physiological mechanisms may be operative in GN that in conjunction with the occurrence of HOCL-modified alter glomerular eNOS expression either at the transcripproteins [28, 33] . tional or post-transcriptional level. As discussed before, studies in experimental models of GN and human renal CONCLUSIONS biopsies indicate that the development of glomerulonephritis is associated with a decrease in overall glomerular This article summarizes the evidence supporting a protective role for eNOS-derived NO in the development eNOS expression. In most cases, this loss of eNOS protein expression appears to be secondary to severe gloof GN. This evidence includes the demonstration of reduced endothelial NO production in GN that may occur merular inflammation causing endothelial cell necrosis. effects on platelet aggregation and leukocyte adhesion. 
